相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The impact of different stereotactic radiation therapy regimens for brain metastases on local control and toxicity
Rachel B. Jimenez et al.
ADVANCES IN RADIATION ONCOLOGY (2017)
Activation of the c-Met Pathway Mobilizes an Inflammatory Network in the Brain Microenvironment to Promote Brain Metastasis of Breast Cancer
Fei Xing et al.
CANCER RESEARCH (2016)
Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas
Jaishri O. Blakeley et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
An allograft mouse model for the study of hearing loss secondary to vestibular schwannoma growth
Nicolas-Xavier Bonne et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Crizotinib inhibits NF2-associated schwannoma through inhibition of focal adhesion kinase 1
Scott Troutman et al.
ONCOTARGET (2016)
AAO: Autoimmune and Autoinflammatory (Disease) in Otology: What is New in Immune-Mediated Hearing Loss
Andrea Vambutas et al.
LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY (2016)
Interplay between VEGF-A and cMET signaling in human vestibular schwannomas and schwann cells
Sonam Dilwali et al.
CANCER BIOLOGY & THERAPY (2015)
Anti-VEGF treatment improves neurological function and augments radiation response in NF2 schwannoma model
Xing Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Secreted Factors from Human Vestibular Schwannomas Can Cause Cochlear Damage
Sonam Dilwali et al.
SCIENTIFIC REPORTS (2015)
HGF/c-MET Axis in Tumor Microenvironment and Metastasis Formation
Anna Spina et al.
BIOMEDICINES (2015)
CLINICAL RESPONSE TO BEVACIZUMAB IN SCHWANNOMATOSIS
Jaishri Blakeley et al.
NEUROLOGY (2014)
Natural History of Vestibular Schwannoma Growth and Hearing Decline in Newly Diagnosed Neurofibromatosis Type 2 Patients
Scott R. Plotkin et al.
OTOLOGY & NEUROTOLOGY (2014)
c-Met signaling in the development of tumorigenesis and chemoresistance: Potential applications in pancreatic cancer
Daniel Delitto et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Modulation of c-Met signaling and cellular sensitivity to radiation Potential Implications for Therapy
Vikas Bhardwaj et al.
CANCER (2013)
Microarray analysis of gene expression in vestibular schwannomas reveals SPP1/MET signaling pathway and androgen receptor deregulation
Miguel Torres-Martin et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
Rakesh K. Jain
JOURNAL OF CLINICAL ONCOLOGY (2013)
Cytokine Levels in the Serum of Healthy Subjects
Giulio Kleiner et al.
MEDIATORS OF INFLAMMATION (2013)
The HGF-Met Signaling Axis: Emerging Themes and Targets of Inhibition
David T. Coleman et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2012)
MET inhibition in tumor cells by PHA665752 impairs homologous recombination repair of DNA double strand breaks
Michaela Medova et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Bevacizumab for Progressive Vestibular Schwannoma in Neurofibromatosis Type 2: A Retrospective Review of 31 Patients
Scott R. Plotkin et al.
OTOLOGY & NEUROTOLOGY (2012)
Mechanisms of Hearing Loss in Neurofibromatosis Type 2
Ashok R. Asthagiri et al.
PLOS ONE (2012)
The seed and soil hypothesis revisited-The role of tumor-stroma interactions in metastasis to different organs
Robert R. Langley et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Emerging therapeutic targets in schwannomas and other merlin-deficient tumors
Sylwia Ammoun et al.
NATURE REVIEWS NEUROLOGY (2011)
An overview of the c-MET signaling pathway
Shawna Leslie Organ et al.
Therapeutic Advances in Medical Oncology (2011)
Local application of hepatocyte growth factor using gelatin hydrogels attenuates noise-induced hearing loss in guinea pigs
Takatoshi Inaoka et al.
ACTA OTO-LARYNGOLOGICA (2009)
Hepatocyte growth factor protects endothelial cells against gamma ray irradiation-induced damage
Shun-ying Hu et al.
ACTA PHARMACOLOGICA SINICA (2009)
Noncoding Mutations of HGF Are Associated with Nonsyndromic Hearing Loss, DFNB39
Julie M. Schultz et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells
Eric Sulpice et al.
BIOLOGY OF THE CELL (2009)
Hepatocyte Growth Factor Protects Auditory Hair Cells From Aminoglycosides
Yayoi S. Kikkawa et al.
LARYNGOSCOPE (2009)
Hearing Improvement after Bevacizumab in Patients with Neurofibromatosis Type 2
Scott R. Plotkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Concordance of Bilateral Vestibular Schwannoma Growth and Hearing Changes in Neurofibromatosis 2: Neurofibromatosis 2 Natural History Consortium
Laurel M. Fisher et al.
OTOLOGY & NEUROTOLOGY (2009)
The Met tyrosine kinase receptor in development and cancer
Alessandra Gentile et al.
CANCER AND METASTASIS REVIEWS (2008)
The biological role of HGF-MET axis in tumor growth and development of metastasis
Ewa Lesko et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions
Kunio Matsumoto et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Hearing changes after diagnosis in neurofibromatosis Type 2
A Masuda et al.
OTOLOGY & NEUROTOLOGY (2004)
Intrathecal injection of HVJ-E containing HGF gene to cerebrospinal fluid can prevent and ameliorate hearing impairment in rats
K Oshima et al.
FASEB JOURNAL (2004)
Met, metastasis, motility and more
C Birchmeier et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation
YW Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Hearing deterioration in patients with a non-growing vestibular schwannoma
K Graamans et al.
ACTA OTO-LARYNGOLOGICA (2003)
分享论文
